CTIS2022-502456-31-00招募中1 期
A Phase 1, Open-Label, Multicenter Study of INCA033890 in Participants with Advanced or Metastatic Solid Tumors
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- Incyte Corp.
- 入组人数
- 165
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
招募中
1 期
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative NeoplasmsJPRN-jRCT2031230426eda Eiji225
已完成
不适用
A Phase 1, Open-Label, multicenter Study of INCA00186 as monotherapy or in combination with immunotherapy in participants with advanced solid tumorsAdvanced Solid Tumors10027656NL-OMON53794Incyte Corporation35
进行中（未招募）
不适用
A study to be conducted in many countries in patients who are known or believed to have a harmful build-up of substances in the arteries that supply blood to the heart to assess whether images that show how a test compound, flurpiridaz F 18 injection, is distributed within the heart can be used by Doctors to determine if there is such a harmful build-upEUCTR2012-002678-29-FIantheus Medical Imaging, Inc.672
进行中（未招募）
不适用
A study to be conducted in many countries in patients who are known or believed to have a harmful build-up of substances in the arteries that supply blood to the heart to assess whether images that show how a test compound, flurpiridaz F 18 injection, is distributed within the heart can be used by Doctors to determine if there is such a harmful build-upAssessment of myocardial perfusion using Positron Emission Tomography (PET) Imaging of Flurpiridaz F 18 Injection in patients with suspected or known coronary artery disease.MedDRA version: 14.1Level: LLTClassification code 10068617Term: Coronary heart diseaseSystem Organ Class: 100000004849EUCTR2010-024044-15-FIantheus Medical Imaging, Inc.740
招募中
1 期
Multicenter, open label, phase I study of intracranial injection of NK-92/5.28.z cells in patients with recurrent HER2-positive glioblastoma (CAR2BRAIN)C71Malignant neoplasm of brainDRKS00013333Goethe-Universität Frankfurt am Main42